<VariationArchive VariationID="53025" VariationName="NM_000218.3(KCNQ1):c.1892_1911del (p.Pro631fs)" VariationType="Deletion" Accession="VCV000053025" Version="33" RecordType="classified" NumberOfSubmissions="9" NumberOfSubmitters="9" DateLastUpdated="2024-07-29" DateCreated="2015-07-05" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="67693" VariationID="53025">
      <GeneList>
        <Gene Symbol="KCNQ1" FullName="potassium voltage-gated channel subfamily Q member 1" GeneID="3784" HGNC_ID="HGNC:6294" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11p15.5-15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="2445008" stop="2849105" display_start="2445008" display_stop="2849105" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NT_187585.1" start="1031" stop="81270" display_start="1031" display_stop="81270" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="2466220" stop="2870339" display_start="2466220" display_stop="2870339" Strand="+" />
          </Location>
          <OMIM>607542</OMIM>
          <Haploinsufficiency last_evaluated="2020-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KCNQ1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-10-13" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KCNQ1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
        <Gene Symbol="KCNQ1-AS1" FullName="KCNQ1 antisense RNA 1" GeneID="338653" HGNC_ID="HGNC:42790" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11p15.4</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="2840135" stop="2861569" display_start="2840135" display_stop="2861569" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NT_187585.1" start="72299" stop="93727" display_start="72299" display_stop="93727" Strand="-" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000218.3(KCNQ1):c.1892_1911del (p.Pro631fs)</Name>
      <CanonicalSPDI>NC_000011.10:2847862:CCCAGAGAGGGCGGGGCCCAC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p15.4</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="2847863" stop="2847882" display_start="2847863" display_stop="2847882" variantLength="20" positionVCF="2847862" referenceAlleleVCF="CCCCAGAGAGGGCGGGGCCCA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="2869093" stop="2869112" display_start="2869093" display_stop="2869112" variantLength="20" positionVCF="2869092" referenceAlleleVCF="CCCCAGAGAGGGCGGGGCCCA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>P631fs</ProteinChange>
      <ProteinChange>P504fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000218.2" sequenceAccession="NM_000218" sequenceVersion="2" change="c.1892_1911delCCAGAGAGGGCGGGGCCCAC">
            <Expression>NM_000218.2:c.1892_1911delCCAGAGAGGGCGGGGCCCAC</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.2847864_2847883del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.2847864_2847883del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.2869094_2869113del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.2869094_2869113del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008935.1" sequenceAccession="NG_008935" sequenceVersion="1" change="g.407874_407893del">
            <Expression>NG_008935.1:g.407874_407893del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000218.2" sequenceAccession="NM_000218" sequenceVersion="2" change="c.1892_1911del20">
            <Expression>NM_000218.2:c.1892_1911del20</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000209.2" sequenceAccession="NP_000209" sequenceVersion="2" change="p.Pro631Hisfs">
            <Expression>NP_000209.2:p.Pro631Hisfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000218.3" sequenceAccession="NM_000218" sequenceVersion="3" change="c.1892_1911del" MANESelect="true">
            <Expression>NM_000218.3:c.1892_1911del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000209.2" sequenceAccession="NP_000209" sequenceVersion="2" change="p.Pro631fs">
            <Expression>NP_000209.2:p.Pro631fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001406836.1" sequenceAccession="NM_001406836" sequenceVersion="1" change="c.1796_1815del20">
            <Expression>NM_001406836.1:c.1796_1815del20</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001393765.1" sequenceAccession="NP_001393765" sequenceVersion="1" change="p.Pro599Hisfs">
            <Expression>NP_001393765.1:p.Pro599Hisfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001406837.1" sequenceAccession="NM_001406837" sequenceVersion="1" change="c.1622_1641del20">
            <Expression>NM_001406837.1:c.1622_1641del20</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001393766.1" sequenceAccession="NP_001393766" sequenceVersion="1" change="p.Pro541Hisfs">
            <Expression>NP_001393766.1:p.Pro541Hisfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001406838.1" sequenceAccession="NM_001406838" sequenceVersion="1" change="c.1352_1371del20">
            <Expression>NM_001406838.1:c.1352_1371del20</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001393767.1" sequenceAccession="NP_001393767" sequenceVersion="1" change="p.Pro451Hisfs">
            <Expression>NP_001393767.1:p.Pro451Hisfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001406839.1" sequenceAccession="NM_001406839" sequenceVersion="1" change="c.404_423del20">
            <Expression>NM_001406839.1:c.404_423del20</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001393768.1" sequenceAccession="NP_001393768" sequenceVersion="1" change="p.Pro135Hisfs">
            <Expression>NP_001393768.1:p.Pro135Hisfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181798.2" sequenceAccession="NM_181798" sequenceVersion="2" change="c.1511_1530del20">
            <Expression>NM_181798.2:c.1511_1530del20</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_861463.1" sequenceAccession="NP_861463" sequenceVersion="1" change="p.Pro504Hisfs">
            <Expression>NP_861463.1:p.Pro504Hisfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_040711.2" sequenceAccession="NR_040711" sequenceVersion="2" change="n.1785_1804del20">
            <Expression>NR_040711.2:n.1785_1804del20</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_287" sequenceAccession="LRG_287">
            <Expression>LRG_287:g.407874_407893del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_287t1" sequenceAccession="LRG_287t1">
            <Expression>LRG_287t1:c.1892_1911del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_287t2" sequenceAccession="LRG_287t2">
            <Expression>LRG_287t2:c.1511_1530del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_287p2" sequenceAccession="LRG_287p2" change="p.Pro504fs">
            <Expression>LRG_287p2:p.Pro504fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA006551" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="607542.0026" DB="OMIM" />
        <XRef Type="rs" ID="397508103" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.1892_1911del (p.Pro631fs) AND Jervell and Lange-Nielsen syndrome 1" Accession="RCV000003285" Version="7">
        <ClassifiedConditionList TraitSetID="799">
          <ClassifiedCondition DB="MedGen" ID="C4551509">Jervell and Lange-Nielsen syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1999-02-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.1892_1911del (p.Pro631fs) AND not provided" Accession="RCV000182287" Version="21">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-01" SubmissionCount="2">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.1892_1911del (p.Pro631fs) AND Long QT syndrome" Accession="RCV001386478" Version="11">
        <ClassifiedConditionList TraitSetID="8775">
          <ClassifiedCondition DB="MedGen" ID="C0023976">Long QT syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-09-22" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.1892_1911del (p.Pro631fs) AND multiple conditions" Accession="RCV002490606" Version="2">
        <ClassifiedConditionList TraitSetID="10474">
          <ClassifiedCondition DB="MedGen" ID="C1837014">Atrial fibrillation, familial, 3</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0004903">Beckwith-Wiedemann syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4551509">Jervell and Lange-Nielsen syndrome 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C4551647">Long QT syndrome 1</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1865019">Short QT syndrome type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-09-12" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.1892_1911del (p.Pro631fs) AND Cardiovascular phenotype" Accession="RCV002408547" Version="3">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-09-24" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.1892_1911del (p.Pro631fs) AND Cardiac arrhythmia" Accession="RCV003591641" Version="1">
        <ClassifiedConditionList TraitSetID="32411">
          <ClassifiedCondition DB="MedGen" ID="C0003811">Cardiac arrhythmia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-01-26" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000218.3(KCNQ1):c.1892_1911del (p.Pro631fs) AND KCNQ1-related disorder" Accession="RCV004537220" Version="1">
        <ClassifiedConditionList TraitSetID="33473">
          <ClassifiedCondition DB="MedGen" ID="CN239322">KCNQ1-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-04" NumberOfSubmissions="9" NumberOfSubmitters="9" DateCreated="2015-07-05" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10024302</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16414944</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19825999</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22739119</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26669661</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27379800</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32893267</ID>
        </Citation>
        <DescriptionHistory Dated="2022-11-28">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="8775" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16506" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Long QT syndrome</ElementValue>
                <XRef ID="Long+QT+Syndrome/4296" DB="Genetic Alliance" />
                <XRef ID="MONDO:0002442" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS192500" DB="OMIM" />
                <XRef ID="9651007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LQTS</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">LQT</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="mode of inheritance">Various modes of inheritance</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000522197" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528536" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520063" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592276" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528500" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558315" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520446" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000515873" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000523361" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528497" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520456" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000555634" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591169" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501111" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000525920" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520478" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000519089" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522200" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000559512" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552322" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520458" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000511116" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000552174" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the EKG that are associated with tachyarrhythmias, typically the ventricular tachycardia torsade de pointes (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Such cardiac events typically occur during exercise and emotional stress, less frequently during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of untreated individuals with a pathogenic variant in one of the genes associated with LQTS have symptoms, usually one to a few syncopal events. While cardiac events may occur from infancy through middle age, they are most common from the preteen years through the 20s. Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7); hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8); and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome.</Attribute>
                <XRef ID="NBK1129" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="general" Abbrev="AHRQ, 2013">
                <ID Source="BookShelf">NBK248310</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="HRS/EHRA/APHRS, 2013">
                <ID Source="PubMed">23994779</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="C0023976" DB="MedGen" />
              <XRef ID="D008133" DB="MeSH" />
              <XRef ID="MONDO:0002442" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="33473" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="36519" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">KCNQ1-Related Disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">KCNQ1-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">KCNQ1-related disorder</ElementValue>
              </Name>
              <XRef ID="CN239322" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10474" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2703" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Long QT syndrome 1</ElementValue>
                <XRef ID="Long+QT+syndrome+1/4297" DB="Genetic Alliance" />
                <XRef ID="MONDO:0100316" DB="MONDO" />
                <XRef ID="MONDO:0008646" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LQT1</ElementValue>
                <XRef ID="GTR000558497" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="192500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the EKG that are associated with tachyarrhythmias, typically the ventricular tachycardia torsade de pointes (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Such cardiac events typically occur during exercise and emotional stress, less frequently during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of untreated individuals with a pathogenic variant in one of the genes associated with LQTS have symptoms, usually one to a few syncopal events. While cardiac events may occur from infancy through middle age, they are most common from the preteen years through the 20s. Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7); hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8); and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome.</Attribute>
                <XRef ID="NBK1129" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3284" />
                <XRef ID="3284" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="101016" DB="Orphanet" />
              <XRef ID="768" DB="Orphanet" />
              <XRef ID="C4551647" DB="MedGen" />
              <XRef ID="MONDO:0100316" DB="MONDO" />
              <XRef Type="MIM" ID="192500" DB="OMIM" />
            </Trait>
            <Trait ID="562" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Atrial fibrillation, familial, 3</ElementValue>
                <XRef ID="Atrial+fibrillation%2C+familial%2C+3/7734" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011857" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ATFB3</ElementValue>
                <XRef Type="MIM" ID="607554" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15414" />
                <XRef ID="15414" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng196</URL>
                <CitationText>UK NICE Guideline NG196, Atrial fibrillation: diagnosis and management, 2021</CitationText>
              </Citation>
              <XRef ID="C1837014" DB="MedGen" />
              <XRef ID="MONDO:0011857" DB="MONDO" />
              <XRef Type="MIM" ID="607554" DB="OMIM" />
            </Trait>
            <Trait ID="5349" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Deafness, congenital, and functional heart disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Prolonged QT interval in EKG and sudden death</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cardioauditory syndrome of Jervell and Lange-Nielsen</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Surdo-cardiac syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Jervell and Lange-Nielsen syndrome 1</ElementValue>
                <XRef ID="MONDO:0024540" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">JLNS1</ElementValue>
                <XRef Type="MIM" ID="220400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Jervell and Lange-Nielsen Syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Jervell and Lange-Nielsen syndrome (JLNS) is characterized by congenital profound bilateral sensorineural hearing loss and long QTc, usually &gt;500 msec. Prolongation of the QTc interval is associated with tachyarrhythmias, including ventricular tachycardia, episodes of torsade de pointes ventricular tachycardia, and ventricular fibrillation, which may culminate in syncope or sudden death. Iron-deficient anemia and elevated levels of gastrin are also frequent features of JLNS. The classic presentation of JLNS is a deaf child who experiences syncopal episodes during periods of stress, exercise, or fright. Fifty percent of individuals with JLNS had cardiac events before age three years. More than half of untreated children with JLNS die before age 15 years.</Attribute>
                <XRef ID="NBK1405" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301579</ID>
                <ID Source="BookShelf">NBK1405</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2002">
                <ID Source="pmc">3110944</ID>
              </Citation>
              <XRef ID="768" DB="Orphanet" />
              <XRef ID="90647" DB="Orphanet" />
              <XRef ID="C4551509" DB="MedGen" />
              <XRef ID="MONDO:0024540" DB="MONDO" />
              <XRef Type="MIM" ID="220400" DB="OMIM" />
            </Trait>
            <Trait ID="589" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Beckwith-Wiedemann syndrome</ElementValue>
                <XRef ID="Beckwith-Wiedemann+Syndrome/774" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007534" DB="MONDO" />
                <XRef ID="81780002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Exomphalos macroglossia gigantism syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">EMG Syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">BWS</ElementValue>
                <XRef Type="MIM" ID="130650" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">WBS</ElementValue>
                <XRef Type="MIM" ID="130650" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Beckwith-Wiedemann syndrome (BWS) is a growth disorder variably characterized by neonatal hypoglycemia, macrosomia, macroglossia, hemihyperplasia, omphalocele, embryonal tumors (e.g., Wilms tumor, hepatoblastoma, neuroblastoma, and rhabdomyosarcoma), visceromegaly, adrenocortical cytomegaly, renal abnormalities (e.g., medullary dysplasia, nephrocalcinosis, medullary sponge kidney, and nephromegaly), and ear creases/pits. BWS is considered a clinical spectrum, in which affected individuals may have many of these features or may have only one or two clinical features. Early death may occur from complications of prematurity, hypoglycemia, cardiomyopathy, macroglossia, or tumors. However, the previously reported mortality of 20% is likely an overestimate given better recognition of the disorder along with enhanced treatment options. Macroglossia and macrosomia are generally present at birth but may have postnatal onset. Growth rate slows around age seven to eight years. Hemihyperplasia may affect segmental regions of the body or selected organs and tissues.</Attribute>
                <XRef ID="NBK1394" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3343" />
                <XRef ID="3343" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301471</ID>
                <ID Source="BookShelf">NBK1294</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301568</ID>
                <ID Source="BookShelf">NBK1394</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2001">
                <ID Source="pmc">3111049</ID>
              </Citation>
              <Citation Type="general" Abbrev="Italian BWS Association, 2016">
                <ID Source="PubMed">26592461</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2020">
                <ID Source="PubMed">32296163</ID>
              </Citation>
              <XRef ID="116" DB="Orphanet" />
              <XRef ID="C0004903" DB="MedGen" />
              <XRef ID="MONDO:0007534" DB="MONDO" />
              <XRef Type="MIM" ID="130650" DB="OMIM" />
            </Trait>
            <Trait ID="5908" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Short QT syndrome type 2</ElementValue>
                <XRef ID="MONDO:0012313" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SQT2</ElementValue>
                <XRef Type="MIM" ID="609621" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18634" />
                <XRef ID="18634" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <XRef ID="51083" DB="Orphanet" />
              <XRef ID="C1865019" DB="MedGen" />
              <XRef ID="MONDO:0012313" DB="MONDO" />
              <XRef Type="MIM" ID="609621" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="32411" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1082" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cardiac arrhythmia</ElementValue>
                <XRef ID="698247007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cardiac rhythm disease</ElementValue>
                <XRef ID="MONDO:0007263" DB="MONDO" />
              </Name>
              <XRef ID="C0003811" DB="MedGen" />
              <XRef ID="EFO_0004269" DB="EFO" />
              <XRef ID="MONDO:0007263" DB="MONDO" />
              <XRef Type="primary" ID="HP:0011675" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001656" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001661" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001665" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001666" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001687" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0001721" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004351" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0005158" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="799" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5349" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Deafness, congenital, and functional heart disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Prolonged QT interval in EKG and sudden death</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cardioauditory syndrome of Jervell and Lange-Nielsen</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Surdo-cardiac syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Jervell and Lange-Nielsen syndrome 1</ElementValue>
                <XRef ID="MONDO:0024540" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">JLNS1</ElementValue>
                <XRef Type="MIM" ID="220400" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Jervell and Lange-Nielsen Syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Jervell and Lange-Nielsen syndrome (JLNS) is characterized by congenital profound bilateral sensorineural hearing loss and long QTc, usually &gt;500 msec. Prolongation of the QTc interval is associated with tachyarrhythmias, including ventricular tachycardia, episodes of torsade de pointes ventricular tachycardia, and ventricular fibrillation, which may culminate in syncope or sudden death. Iron-deficient anemia and elevated levels of gastrin are also frequent features of JLNS. The classic presentation of JLNS is a deaf child who experiences syncopal episodes during periods of stress, exercise, or fright. Fifty percent of individuals with JLNS had cardiac events before age three years. More than half of untreated children with JLNS die before age 15 years.</Attribute>
                <XRef ID="NBK1405" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301579</ID>
                <ID Source="BookShelf">NBK1405</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2002">
                <ID Source="pmc">3110944</ID>
              </Citation>
              <XRef ID="768" DB="Orphanet" />
              <XRef ID="90647" DB="Orphanet" />
              <XRef ID="C4551509" DB="MedGen" />
              <XRef ID="MONDO:0024540" DB="MONDO" />
              <XRef Type="MIM" ID="220400" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="23443" SubmissionDate="2017-02-06" DateLastUpdated="2017-02-09" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="607542.0026_JERVELL AND LANGE-NIELSEN SYNDROME 1" title="KCNQ1, 20-BP DEL, NT1892_JERVELL AND LANGE-NIELSEN SYNDROME 1" />
        <ClinVarAccession Accession="SCV000023443" DateUpdated="2017-02-09" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1999-02-19">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Neyroud et al. (1999) found that a male with Jervell and Lange-Nielsen syndrome (JLNS1; 220400) was compound heterozygous for a frameshift mutation in exon 15 of the KCNQ1 gene and another mutation that was not identified. The frameshift, caused by a 20-bp deletion at nucleotide position 1892, created a premature stop codon 13 amino acids later.</Attribute>
              <Citation>
                <ID Source="PubMed">10024302</ID>
              </Citation>
              <XRef DB="OMIM" ID="220400" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <Name>KCNQ1, 20-BP DEL, NT1892</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">20-BP DEL, NT1892</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="607542.0026" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">JERVELL AND LANGE-NIELSEN SYNDROME 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5452704" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000218.2:c.1892_1911del|OMIM:130650;192500;192500;220400;607554;609621" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002796588" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.2:c.1892_1911del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="130650" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="192500" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="192500" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="220400" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="607554" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="609621" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5204136" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a52914|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002719171" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-09-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10024302</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19825999</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26669661</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27379800</ID>
          </Citation>
          <Comment>The c.1892_1911del20 variant, located in coding exon 16 of the KCNQ1 gene, results from a deletion of 20 nucleotides at nucleotide positions 1892 to 1911, causing a translational frameshift with a predicted alternate stop codon (p.P631Hfs*14). This frameshift occurs at the 3' terminus of KCNQ1, is not expected to trigger nonsense-mediated mRNA decay, and impacts only the last 46 amino acids of the protein. However, this alteration has been previously reported in long QT syndrome cohorts (Itoh H et al. Eur. J. Hum. Genet., 2016 08;24:1160-6; Samol A et al. PLoS ONE, 2016 Jul;11:e0158085). This deletion allele has also been detected in the heterozygous state in a patient with autosomal recessive Jervell and Lange-Nielsen syndrome, though a second KCNQ1 alteration was not identified (Neyroud N et al. Circ. Res., 1999 Feb;84:290-7). In addition, there is a putative endoplasmic reticulum (ER) retention signal located in the 3' terminus of this alteration that is not present in wild-type KCNQ1; the presence of similar ER retention signals in another frameshift alteration (p.R632Qfs*20) has been shown to result in a trafficking defect (Sato A et al. J. Biol. Chem., 2009 Dec;284:35122-33; Ambry Internal data). Based on the majority of available evidence to date, this variant is likely to be pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.2:c.1892_1911del20</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="430889" SubmissionDate="2017-07-13" DateLastUpdated="2015-07-05" DateCreated="2015-07-05">
        <ClinVarSubmissionID localKey="GDX:28746|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000234590" DateUpdated="2015-07-05" DateCreated="2015-07-05" Type="SCV" Version="3" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Comment>The c.1892_1911del pathogenic variant in the KCNQ1 gene has been reported in one family with Jervell Lange-Nielsen syndrome (JLNS) (Neyroud et al., 1999). Neyroud et al. reported c.1892_1911del (denoted 1892del20 due to alternate nomenclature) in one family where this variant was paternally inherited; no second variant was identified in the proband. This variant causes a shift in reading frame starting at codon Proline 631, changing it to a Histidine, and creating a premature stop codon at position 14 of the new reading frame, denoted p.Pro631HisfsX14. This variant is expected to result in either an abnormal, truncated protein product or loss of protein from this allele through nonsense-mediated mRNA decay. Other frameshift variants in the KCNQ1 gene have been reported in association with LQTS and JLNS.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.2:c.1892_1911delCCAGAGAGGGCGGGGCCCAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3112362" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4803745|MedGen:C0023976" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001586712" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10024302</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16414944</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22739119</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Pro631Hisfs*14) in the KCNQ1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 46 amino acid(s) of the KCNQ1 protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Jervell and Lange-Nielsen syndrome (PMID: 10024302). This variant is also known as 1892del20. ClinVar contains an entry for this variant (Variation ID: 53025). This variant disrupts a region of the KCNQ1 protein in which other variant(s) (p.Arg632Glufs*34, p.Arg632Lysfs*20) have been determined to be pathogenic (PMID: 16414944, 22739119; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.2869093_2869112del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0023976" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8042457" SubmissionDate="2024-01-25" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="Db4KrQBSZeoE7-orUyypkXNJWZYrJXEcd1gDTAETnaY|MedGen:C0003811" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004358449" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Color Diagnostics, LLC DBA Color Health" OrgID="505849" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10024302</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26669661</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27379800</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32893267</ID>
          </Citation>
          <Comment>This variant deletes 20 nucleotides in exon 16 of the KCNQ1 gene, creating a frameshift in the last exon. The mutant transcript is expected to escape nonsense-mediated decay and be expressed as a protein product containing altered C-terminal sequence. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in a few unrelated individuals affected with long QT syndrome (PMID: 26669661, 27379800, 32893267). This variant has also been observed in compound heterozygous state in two unrelated individuals, one affected with Jervell and Lange-Nielsen syndrome (PMID: 10024302) and the other affected with early-onset sudden cardiac arrest, ventricular fibrillation, congenital deafness, and with a family history of long QT syndrome (communication with an external laboratory; ClinVar SCV002719171.1). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Truncation variants occurring downstream of this variant are known to cause long QT syndrome (ClinVar). One of these variants, p.Arg632GlnfsTer20 (ClinVar variation ID 53027), has been shown to cause a protein trafficking defect due to endoplasmic reticulum (ER) retention signal introduced by the frameshift. A similar ER retention signal is also present in the variant p.Pro631HisfsTer14. Based on the available evidence, this variant is classified as Likely Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>NGS</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.3:c.1892_1911del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0003811" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14171678</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8815711" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="16640297|KCNQ1-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004728010" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The KCNQ1 c.1892_1911del20 variant is predicted to result in a frameshift and premature protein termination (p.Pro631Hisfs*14). This variant was reported in multiple individuals with long QT syndrome (Table S1, Itoh et al. 2015. PubMed ID: 26669661; Samol et al. 2016. PubMed ID: 27379800; Table S4, Walsh et al. 2021. PubMed ID: 32893267). This variant was also reported in an individual with Jervell and Lange-Nielsen syndrome; however, a second plausible causative variant was not identified (described as 1892del20, Neyroud et al. 1999. PubMed ID: 10024302). This variant has not been reported in a large population database, indicating this variant is rare. This variant is located in the terminal exon and nearby frameshift variants have been documented in individuals with long QT syndrome (Napolitano et al. 2005. PubMed ID: 16414944). Taken together, this variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000218.2:c.1892_1911del20</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">KCNQ1-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9005514" SubmissionDate="2024-04-16" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="604695|MONDO:0002442" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004816524" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="All of Us Research Program, National Institutes of Health" OrgID="509529" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10024302</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26669661</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27379800</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32893267</ID>
          </Citation>
          <Comment>This variant deletes 20 nucleotides in exon 16 of the KCNQ1 gene, creating a frameshift in the last exon. The mutant transcript is expected to escape nonsense-mediated decay and be expressed as a protein product containing altered C-terminal sequence. To our knowledge, functional studies have not been reported for this variant. This variant has been reported in a few unrelated individuals affected with long QT syndrome (PMID: 26669661, 27379800, 32893267). This variant has also been observed in compound heterozygous state in two unrelated individuals, one affected with Jervell and Lange-Nielsen syndrome (PMID: 10024302) and the other affected with early-onset sudden cardiac arrest, ventricular fibrillation, congenital deafness, and with a family history of long QT syndrome (communication with an external laboratory; ClinVar SCV002719171.1). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Truncation variants occurring downstream of this variant are known to cause long QT syndrome (ClinVar). One of these variants, p.Arg632Glnfs*20 (ClinVar variation ID 53027), has been shown to cause protein trafficking defect due to endoplasmic reticulum (ER) retention signal introduced by the frameshift. A similar ER retention signal is also present in the variant p.Pro631Hisfs*14. Based on the available evidence, this variant is classified as Likely Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>108544</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.2869093_2869112del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0002442" />
          </Trait>
        </TraitSet>
        <Comment>This study involves interpretation of variants in research participants for the purpose of population health screening. Participant phenotype was not available at the time of variant classification. Additional details can be found in publication PMID: 35346344, PMCID: PMC8962531</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB14382316</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3849569" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2021-10-08">
        <ClinVarSubmissionID localKey="110902|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001961260" DateUpdated="2024-07-15" DateCreated="2021-10-08" Type="SCV" Version="17" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>KCNQ1: PM2, PS4:Moderate, PVS1:Moderate</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNQ1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="C" referenceAllele="CCCCAGAGAGGGCGGGGCCCA" start="2869092" stop="2869112" variantLength="21" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9005514" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0002442" MappingRef="MONDO">
        <MedGen CUI="C0023976" Name="Long QT syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5452704" TraitType="Disease" MappingType="XRef" MappingValue="130650" MappingRef="OMIM">
        <MedGen CUI="C0004903" Name="Beckwith-Wiedemann syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5204136" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5452704" TraitType="Disease" MappingType="XRef" MappingValue="192500" MappingRef="OMIM">
        <MedGen CUI="C4551647" Name="Long QT syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3849569" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5452704" TraitType="Disease" MappingType="XRef" MappingValue="192500" MappingRef="OMIM">
        <MedGen CUI="C4551647" Name="Long QT syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3112362" TraitType="Disease" MappingType="XRef" MappingValue="C0023976" MappingRef="MedGen">
        <MedGen CUI="C0023976" Name="Long QT syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8042457" TraitType="Disease" MappingType="XRef" MappingValue="C0003811" MappingRef="MedGen">
        <MedGen CUI="C0003811" Name="Cardiac arrhythmia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5452704" TraitType="Disease" MappingType="XRef" MappingValue="220400" MappingRef="OMIM">
        <MedGen CUI="C4551509" Name="Jervell and Lange-Nielsen syndrome 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5452704" TraitType="Disease" MappingType="XRef" MappingValue="609621" MappingRef="OMIM">
        <MedGen CUI="C1865019" Name="Short QT syndrome type 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="430889" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8815711" TraitType="Disease" MappingType="Name" MappingValue="KCNQ1-related condition" MappingRef="Preferred">
        <MedGen CUI="CN239322" Name="KCNQ1-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5452704" TraitType="Disease" MappingType="XRef" MappingValue="607554" MappingRef="OMIM">
        <MedGen CUI="C1837014" Name="Atrial fibrillation, familial, 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="23443" TraitType="Disease" MappingType="Name" MappingValue="JERVELL AND LANGE-NIELSEN SYNDROME 1" MappingRef="Preferred">
        <MedGen CUI="C4551509" Name="Jervell and Lange-Nielsen syndrome 1" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="2" DateDeleted="2017-12-11">SCV000074051</Accession>
        <Description>this interpretation was deleted because it was generated with an out-of-date curation method; no clinical information is available to provide a full interpretation of the variant</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

